Concepedia

Andrew Mitchelson

AM

Statistics

Publications

4

Citations

69

H-Index

4

Active since

1986

Affiliations

Novartis (United Kingdom)(Current)

Andrew Mitchelson is an author at Novartis (United Kingdom) specializing in pharmacology, thrombin generation, and thrombin inhibition.

Publications per year

1986–2000

4

Publications

4

Activities of some key enzymes of carbohydrate, ketone body, adenosine and glutamine metabolism in liver, and brown and white adipose tissues of the rat

Greg Cooney, Rui Curi, Andrew Mitchelson et al. · Biochemical and Biophysical Research Communications · 1986 · 33 citations

, , +17

The design and synthesis of thrombin inhibitors: analogues of MD805 containing non-polar surrogates for arginine at the P1 position

Urs Baettig, Lyndon Brown, Derek E. Brundish et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 13 citations · Full text

, , +14

Preclinical Profiling of Modified Oligonucleotides: Anticoagulation and Pharmacokinetic Properties

Paul Nicklin, John Ambler, Andrew Mitchelson et al. · Nucleosides and Nucleotides · 1997 · 12 citations

, , +17

the design and synthesis of thrombin inhibitors: the introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitors

Judy Hayler, Peter D. Kane, Darren LeGrand et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 11 citations · Full text

, , +16

1–4 of 4